Strategies for Improving Linkage-to-Care After Eye Disease Screening
Village Integrated Eye Worker II Linkage-to-Care Trial
2 other identifiers
interventional
3,000
1 country
1
Brief Summary
The goal of this randomized, parallel-group, controlled trial is to compare methods of improving linkage-to-care for participants in the Village Integrated Eye Worker II (VIEW II) trial who are referred to the eye hospital following eye disease screening. Participants who are referred to the hospital at an eye screening visit will be randomized to three different linkage-to-care interventions: (1) text message reminders, (2) reminders from health workers, or (3) no intervention. The primary outcome of the trial will be whether or not the participant presented to the eye hospital for a referral visit by 21 days following screening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2025
CompletedFirst Posted
Study publicly available on registry
April 24, 2025
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2028
April 29, 2026
April 1, 2026
2.4 years
April 11, 2025
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Referral Visit Attendance
The count of participants who attend the referral visit.
21 days after screening
Study Arms (3)
Text Message Reminders
EXPERIMENTALHealth Worker
EXPERIMENTALNo Intervention
NO INTERVENTIONInterventions
Participants referred to the eye hospital after screening will receive a text message reminding them to attend their referral visit.
Participants referred to the eye hospital after screening will receive a home visit from a health worker reminding them to attend their referral visit.
Eligibility Criteria
You may qualify if:
- \- Participant of the VIEW II study referred to the eye hospital at their eye screening visit.
You may not qualify if:
- Residence in an area without reliable mobile connectivity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Franciscolead
- Seva Foundationcollaborator
- National Eye Institute (NEI)collaborator
Study Sites (1)
University of California, San Francisco
San Francisco, California, 94158, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeremy Keenan, MD, MPH
University of California, San Francisco
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 11, 2025
First Posted
April 24, 2025
Study Start
February 1, 2026
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
June 30, 2028
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- De-identified data will be shared after publication of the major findings of the study, which we anticipate will occur around 6 months after the study conclusion.
- Access Criteria
- Other investigators can access the data if approved by the Trial Coordinating Center. Requests should be sent to the study contact(s).
De-identified data including age, cluster identifier, referral visit attendance